Favorable tolerability of Asciminib versus ATP-competitive tyrosine kinase inhibitors in the ASC4FIRST study of newly diagnosed patients with chronic-phase chronic myeloid leukemia
Issa GC et al. Haematologica, July 2026 (epub ahead of print) – open access publication
Link to full abstract